{"id":16912,"date":"2023-05-15T09:14:44","date_gmt":"2023-05-15T08:14:44","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=16912"},"modified":"2023-05-15T09:14:44","modified_gmt":"2023-05-15T08:14:44","slug":"co-investissement-pour-odimma-therapeutics","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/co-investissement-pour-odimma-therapeutics\/","title":{"rendered":"Co-investissement pour Odimma Therapeutics"},"content":{"rendered":"\n

Odimma Therapeutics<\/a><\/strong>, une soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans l’immunoth\u00e9rapie personnalis\u00e9e contre le cancer, annonce une lev\u00e9e de fonds d’amor\u00e7age de 2 millions d’euros afin de s\u00e9curiser la pr\u00e9paration de son essai clinique de phase I avec ODI-2001, une immunoth\u00e9rapie personnalis\u00e9e innovante de nouvelle g\u00e9n\u00e9ration contre le cancer.<\/p>\n\n\n\n\n\n\n\n

Ce tour de table est soutenu par Capital Grand Est<\/a><\/strong>, Alsace Business Angels<\/a><\/strong>, Angels Sant\u00e9<\/a><\/strong>, des fondateurs et associ\u00e9s historiques, plusieurs nouveaux Business Angels et Bpifrance<\/a><\/strong>. <\/p>\n\n\n\n

Au cours des derniers mois, Odimma Therapeutics a achev\u00e9 les exp\u00e9riences de preuve d’activit\u00e9 de son produit phare ODI-2001 dans plusieurs mod\u00e8les pr\u00e9cliniques de cancer difficiles \u00e0 traiter. En parall\u00e8le, la soci\u00e9t\u00e9 a s\u00e9curis\u00e9 le proc\u00e9d\u00e9 pharmaceutique de production d’ODI-2001. Cela s’appuie sur des partenariats pharmaceutiques avec des acteurs de classe mondiale dans le domaine, comme annonc\u00e9 pr\u00e9c\u00e9demment : myNEO (Gand, Belgique) pour la pr\u00e9diction de n\u00e9o\u00e9pitopes par intelligence artificielle, Touchlight Genetics (Hampton, Royaume-Uni) pour la production d’ADN synth\u00e9tique et ABL Europe (Illkirch, France ) pour la production du composant viral d’ODI-2001.<\/p>\n\n\n\n

Les activit\u00e9s actuelles se concentrent sur la pr\u00e9paration de l’essai clinique de phase I chez les patients atteints de tumeurs solides avanc\u00e9es. Ces activit\u00e9s comprennent les interactions r\u00e9glementaires, la toxicologie et les op\u00e9rations cliniques. Les activit\u00e9s de R&D sont renforc\u00e9es pour continuer \u00e0 g\u00e9n\u00e9rer des donn\u00e9es suppl\u00e9mentaires et de la propri\u00e9t\u00e9 intellectuelle.<\/p>\n\n\n\n

Jean-S\u00e9bastien Schmitt<\/em>, repr\u00e9sentant d’Alsace Business Angels a d\u00e9clar\u00e9 : “Lutter contre le cancer avec une technologique de rupture personnalis\u00e9e, plus efficace et rapidement disponible pour le patient \u00e9tait tr\u00e8s attractif pour nos adh\u00e9rents. Nous sommes ravis d’accompagner l’\u00e9quipe d’Odimma dans son ambition et, dans un premier temps, de lui offrir les meilleures conditions pour son essai clinique.<\/em>“<\/p>\n\n\n\n

“Nous nous r\u00e9jouissons du succ\u00e8s de ce nouveau tour de table de refinancement et sommes tr\u00e8s heureux de contribuer au d\u00e9veloppement de cette technologie prometteuse. Nous sommes convaincus que la plateforme innovante d’immunoth\u00e9rapie personnalis\u00e9e d\u00e9velopp\u00e9e par Odimma Therapeutics donnera les meilleures chances de succ\u00e8s \u00e0 l’immunoth\u00e9rapie en oncologie”<\/em> a d\u00e9clar\u00e9 le Docteur Patrick Squiban<\/em>, membre et ambassadeur du r\u00e9seau Angels Sant\u00e9 – Business Angels.<\/p>\n\n\n\n

Le Dr Jean-Marc Limacher, Pr\u00e9sident de la soci\u00e9t\u00e9 a d\u00e9clar\u00e9 : “Le soutien renouvel\u00e9 des actionnaires historiques et l’engagement de nouveaux investisseurs est une marque de confiance qui reconna\u00eet les avanc\u00e9es r\u00e9alis\u00e9es par la soci\u00e9t\u00e9 et ses collaborateurs. Ce nouvel investissement permettra \u00e0 Odimma Therapeutics d’amener ODI-2001, au stade clinique de son d\u00e9veloppement”.<\/p>\n\n\n\n

Dans le cadre de la pr\u00e9paration de son premier essai clinique, la soci\u00e9t\u00e9 travaille activement au prochain tour de financement.<\/p>\n","protected":false},"excerpt":{"rendered":"

Alsace Business Angels et Angels Sant\u00e9 investissent dans Odimma Therapeutics<\/p>\n","protected":false},"author":114,"featured_media":16921,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[162,85,86],"tags":[214,147,63,75,1030],"yoast_head":"\nCo-investissement pour Odimma Therapeutics - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Co-investissement pour Odimma Therapeutics - France Angels\" \/>\n<meta property=\"og:description\" content=\"Alsace Business Angels et Angels Sant\u00e9 investissent dans Odimma Therapeutics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-15T08:14:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2023\/05\/schema-odimma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1228\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Co-investissement pour Odimma Therapeutics\",\"datePublished\":\"2023-05-15T08:14:44+00:00\",\"dateModified\":\"2023-05-15T08:14:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\"},\"wordCount\":478,\"commentCount\":4699,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Alsace Business Angels\",\"Angels Sant\u00e9\",\"Business Angels\",\"Lev\u00e9e de fonds\",\"Odimma Therapeutics\"],\"articleSection\":[\"2023\",\"Closing\",\"Les entreprises financ\u00e9es\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\",\"name\":\"Co-investissement pour Odimma Therapeutics - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2023-05-15T08:14:44+00:00\",\"dateModified\":\"2023-05-15T08:14:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Co-investissement pour Odimma Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Co-investissement pour Odimma Therapeutics - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Co-investissement pour Odimma Therapeutics - France Angels","og_description":"Alsace Business Angels et Angels Sant\u00e9 investissent dans Odimma Therapeutics","og_url":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2023-05-15T08:14:44+00:00","og_image":[{"width":1228,"height":540,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2023\/05\/schema-odimma.jpg","type":"image\/jpeg"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Co-investissement pour Odimma Therapeutics","datePublished":"2023-05-15T08:14:44+00:00","dateModified":"2023-05-15T08:14:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/"},"wordCount":478,"commentCount":4699,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Alsace Business Angels","Angels Sant\u00e9","Business Angels","Lev\u00e9e de fonds","Odimma Therapeutics"],"articleSection":["2023","Closing","Les entreprises financ\u00e9es"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/","url":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/","name":"Co-investissement pour Odimma Therapeutics - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2023-05-15T08:14:44+00:00","dateModified":"2023-05-15T08:14:44+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/co-investissement-pour-odimma-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Co-investissement pour Odimma Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/16912"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=16912"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/16912\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/16921"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=16912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=16912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=16912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}